Health Novel immunotherapy agent safe, shows promise against high-risk prostate cancers James Pereira Apr 11, 2023 A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce… Read More...
Health The new prostate cancer blood test with 94 per cent accuracy James Pereira Feb 9, 2023 Researchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greater… Read More...
Health Neuronal molecule makes prostate cancer more aggressive: Researchers discover a potential… James Pereira Jan 26, 2023 Prostate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now,… Read More...
Health Scientists identify multiple cell types that may contribute to treatment resistance in prostate… James Pereira Dec 14, 2022 Researchers have characterised prostate cancer cell dynamics at a single-cell resolution across the timespan of the… Read More...
Health How prostate cancer may begin James Pereira Sep 25, 2022 Researchers at the University of East Anglia have made an important discovery about how prostate cancer may start to… Read More...
Health Prognosis of prostate cancer patients improved James Pereira Jul 19, 2022 Prostate cancer is the most common form of cancer in male in Sweden. Researchers at Umeå University in Sweden have now… Read More...
Health Mechanism leading to drug resistance in prostate cancer: Consecutive molecular modifications of the… James Pereira Jun 16, 2022 Prostate cancer is the most common cancer among men in the United States. Many patients can live long lives due to early… Read More...
Health Less prostate cancer screening reduces overdiagnosis but may miss aggressive cases James Pereira Apr 22, 2022 Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen… Read More...
Health New risk algorithm would improve screening for prostate cancer James Pereira Mar 8, 2022 Calculating a person's risk of developing prostate cancer using results from two blood markers would improve the… Read More...
Health Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer James Pereira Feb 20, 2022 Results from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding… Read More...